Wall Street Journal (blog) |
UK Biotech Circassia Moves Into Asthma With Two Acquisitions
Wall Street Journal (blog) Allergy and asthma are natural bedfellows: That's the rationale behind Circassia Pharmaceuticals PLC's acquisition spree announced Friday. The Oxford, England, biotech, which is developing vaccines for a range of allergies, has bought Swedish-listed … UK's Circassia buys two asthma-focused firms for up to $377 million Circassia Pharma buys two asthma-focussed companies Circassia In Share Sale To Fund GBP239 Million In Acquisitions (ALLISS) |
View full post on asthma – Google News